Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia

Authors: Christie M. Ballantyne, Szilard Vasas, Masoud Azizad, Peter Clifton, Robert S. Rosenson, Ting Chang, Stacey Melquist, Rong Zhou, Ma’an Mushin, Nicholas J. Leeper, Jennifer Hellawell, Daniel Gaudet

Published: 2024-05-28

DOI: 10.1056/nejmoa2404143

Source: Full article

---

Abstract

No abstract found.